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Melanocortin-1 Receptor Agonists
The melanocortin peptides that include the α-, β-, γ-melanocyte stimulating hormones (MSH)
and adrenocorticotrophin (ACTH) all possess a His-Phe-Arg-Trp epitope that is known as the
‘message’ sequence. These peptides are responsible for a range of physiological actions
including skin pigmentation, energy homeostasis and adrenocortical steroidogenesis. Five
melanocortin receptors have been identified to date, with the MC1R receptor involved in skin
pigmentation. As the bioactive conformation of the MSH peptides is based on a peptide β-
turn, a recent study has focused on the synthesis of a library of small molecules based upon
this structural feature (Compounds That Activate the Mouse Melanocortin-1 Receptor
Identified by Screening a Small Molecule Library Based upon the β-Turn, C. Haskell-Luevano
et al., J. Med. Chem., 42, (1999), 4380-4387).
951 compounds (1) were prepared using solid-phase synthetic methods with side-chains based
on structures known to be important for receptor recognition and activation. The compounds
were evaluated for their ability to activate the melanocortin-1 receptor subtype when tested at
10 µM in a colourimetric bioassay.
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Of the compounds prepared, two were chosen for resynthesis, purification and
characterisation. One of these (2) possessed an EC50 value of 42.5 µM for the mouse MC1R
subtype, whilst not eliciting an agonist response at the mouse MC3R or MC4R subtypes, and
provides a starting point for further studies of non-peptide heterocyclic agonists.
--------------------------------------------------------------------------------------------------------------
Enkephalin mimetics
The solid-phase synthesis of a number of piperazinone-containing Leu-enkephalin mimetics
has been described in a recent paper (Solid Phase Organic Synthesis of Piperazinone
Containing Enkephalin Mimetics: A Readily Derivatized, Traceless Scaffold, K. Shreder et al,
J. Comb. Chem., 1, (1999), 383-387). The preparation of eight analogues followed a synthetic
route that commenced with the acylation of Wang resin with bromoacetyl bromide. The
piperazinone heterocycle was constructed such that acid-catalysed cyclisation of the ring in the
final step also released the product (3) from the solid support leaving no trace of the resin
attachment point.
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The compounds were screened for affinity for the µ and δ opioid receptors and it was found
that compound (4) had an affinity of 400 nM for the µ receptor. This study paves the way for
the synthesis of larger combinatorial libraries of non-peptide enkephalin analogues.
--------------------------------------------------------------------------------------------------------------
β-Amyloid Inhibitors
Alzheimer’s disease is characterised by the formation of amyloid plaques in brain tissue. These
plaques contain a 39-43 amino acid peptide called β-amyloid (Aβ) that is produced by
proteolytic processing of the β-amyloid precursor protein (βAPP). The pathways by which the
processing takes place have not been fully elucidated, although the existence of a family of
enzymes called secretases has been proposed. As both β- and γ-secretase are required for the
formation of Aβ, these enzymes are good targets for therapeutic intervention. Indeed,
aldehydic inhibitors of γ-secretase have already been identified.
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In order to find more potent inhibitors of Aβ formation, a combinatorial library approach to
discovering potent inhibitors of γ-secretase has been undertaken (A Combinatorial Approach
to the Identification of Dipeptide Aldehyde Inhibitors of β-Amyloid Production, J.N. Higaki et
al., J. Med. Chem., 42, (1999), 3889-3898). The solid-phase combinatorial synthesis of
mixtures of 10 related peptide aldehydes was successfully achieved using reduction of a
Weinreb amide intermediate to generate the aldehyde function. Following screening and
deconvolution, the most active aldehyde (5), was discovered to inhibit Aβ formation with an
IC50 value of 9.6 µM.
